Cargando…
Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2
Autores principales: | Liao, L, Bonsignori, M, Hwang, K, Moody, AM, Park, R, Crawford, S, Chen, H, Jeffries, TL, Cooper, M, Lu, X, De, R, Karasavvas, N, Rerks-Ngarm, S, Nitayaphan, S, Kaewkungwal, J, Tovanabutra, S, Pitisuttithum, P, Tartaglia, J, Sinangil, F, Kim, J, Michael, NL, Tomaras, GD, Yang, Z, Dai, K, Pancera, M, Nabel, GJ, Mascola, JR, Kwong, PD, Pinter, A, Zolla-Pazner, S, Alam, MS, Haynes, BF |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441578/ http://dx.doi.org/10.1186/1742-4690-9-S2-O31 |
Ejemplares similares
-
V1/V2-directed antibodies elicited in RV144 vaccinees bind to a structurally polymorphic site
por: McLellan, JS, et al.
Publicado: (2012) -
Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor
por: Peachman, Kristina K., et al.
Publicado: (2015) -
Antibody responses to V2 loop are induced by CRF01_A E and not Clade B envelopes
por: Karasavvas, N, et al.
Publicado: (2012) -
Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay
por: Rao, M, et al.
Publicado: (2012) -
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial preferentially use the VH1 gene family
por: Bonsignori, M, et al.
Publicado: (2012)